Member access

4-Traders Homepage  >  Shares  >  Copenhagen Stock Exchange  >  Novo Nordisk A/S    NOVO.B   DK0060534915

NOVO NORDISK A/S (NOVO.B)

178
 SummaryChart AnalysisNewsCalendarCompanyFinancialsConsensusRevisions 
Quotes 5-day view   End-of-day quote. End-of-day quote Copenhagen Stock Exchange
11/17/2014 11/18/2014 11/19/2014 11/20/2014 11/21/2014 Date
261.5 261.5 264.5 263.8 265.8 Last
2020706 1670285 2069035 1888408 1768251 Volume
+0.15% 0.00% +1.15% -0.26% +0.76% Change
Company
Novo Nordisk AS is engaged in the development, manufacture, and marketing of pharmaceutical products.It operates through the Diabetes Care and Biopharmaceuticals segments.The Diabetes Care segment deals with the research, development, manufacture, and marketing of products within the areas of... 
Sector
Pharmaceuticals
Calendar
12/04Presentation
Surperformance© rating of Novo Nordisk A/S
Trading Rating : Investor Rating :
More about the company
Chart NOVO NORDISK A/S
Duration : Period :
Novo Nordisk A/S Technical Analysis Chart | NOVO.B | DK0060534915 | 4-Traders
Full-screen chart
Financials ( DKK)
Sales 2014 88 468 M
EBIT 2014 33 978 M
Net income 2014 26 254 M
Finance 2014 10 731 M
Yield 2014 1,80%
Sales 2015 97 889 M
EBIT 2015 38 837 M
Net income 2015 29 515 M
Finance 2015 11 734 M
Yield 2015 2,06%
PER 2014 26,37
PER 2015 22,89
EV / Sales 2014 6,18x
EV / Sales 2015 5,57x
Capitalization 557 294 M
More Financials
Latest news on NOVO NORDISK A/S
10h ago NOVO NORDISK A/S : Victoza® receives positive CHMP opinion for use in adults wit..
2d ago NOVO NORDISK A/S : Patent Issued for Human Insulin Containing Additional Disulfi..
2d ago NOVO NORDISK A/S : Patent Issued for Single-Chain Insulin
4d ago NOVO NORDISK A/S : -Tianjin and Shanghai join Cities Changing Diabetes on World ..
4d ago Novo Nordisk A/S - Share repurchase programme
4d ago NOVO NORDISK A/S : second best in the world at providing access to medicine
11/12 NOVO NORDISK A/S : Researchers from Novo Nordisk Provide Details of New Studies ..
11/12 NOVO NORDISK A/S : Research Conducted at Novo Nordisk Has Updated Our Knowledge ..
11/12 NOVO NORDISK A/S : City of Houston and Novo Nordisk Partner to Lead Fight Agains..
11/12 NOVO NORDISK A/S : High number of diabetics causes alarm
11/11 NOVO NORDISK A/S : Share repurchase programme
11/10 NOVO NORDISK A/S : Novo Nordisk A/S - Share repurchase programme
More news


Comments 
Advertisement
Technical analysis trends
Short TermMid-TermLong Term
TrendsNeutralNeutralBullish
Technical analysis
Income Statement Evolution
More Financials
EPS Revisions
More Estimates Revisions
Dynamic quotes  
ON
| OFF